🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

30 notícias encontradas para "insulin"
Foto: Nataliya Vaitkevich / Pexels
Type 2 diabetes patients often have high blood sugar while fasting—here's why
Many patients with type 2 diabetes wonder how their blood sugar levels can be high when they have not eaten anything. The answer to this counterintuitive phenomenon lies in what is known as insulin resistance.
Foto: Jay Brand / Pexels
Two studies point to beta cells as active players in type 1 diabetes
Type 1 diabetes is widely understood as an autoimmune disease, with the immune system attacking the insulin-producing beta cells of the pancreas. But two new studies suggest those cells may be more than passive victims. Together, the findings indicate that beta cells' own stress
Newer insulin may reduce low blood sugar in youth with type 1 diabetes
A trial led by University of Pittsburgh researchers and published today in The Lancet Diabetes & Endocrinology adds nuance to the question of whether older human insulins are as effective as insulin analogs in low-resource settings.
Anion gap remains pragmatic target during diabetic ketoacidosis treatment and resolution
Patients experiencing life-threatening diabetic ketoacidosis (DKA) require quick action, diligent care and close monitoring as they receive insulin infusions and other medical interventions to bring their blood glucose and ketone levels back into balance.
FDA approves Tzield for children with new stage 3 type 1 diabetes
The U.S. Food and Drug Administration has granted accelerated approval to Sanofi's Tzield (teplizumab-mzwv) to delay the decline in endogenous insulin production in children aged 8 to 17 years recently diagnosed with stage 3 type 1 diabetes.
Movement breaks reduce health risks
People who sit at a desk for most of the day know the importance of taking a break, but new University of Otago—Ōtākou Whakaihu Waka research has determined exactly how often they should get up and move around. The study found taking a short walking break every 20 minutes leads t
New first-in-human study explores immune-engineered cell therapy approach for type 1 diabe
New first-in-human study explores immune-engineered cell therapy approach for type 1 diabe
New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach that could expand the potential of cell replacement therapy for type 1 diabetes by evaluating whether immune-engineered, allogeneic insulin-producing cells
Foto: Artem Podrez / Pexels
Preclinical study points to a promising combined strategy for slowing the progression of t
An international research group led by researchers from VUB-UZ Brussels and KU Leuven has demonstrated that a combined approach targeting both the immune system and insulin-producing beta cells can slow the progression of type 1 diabetes more effectively than individual treatment
Primary care initiation of continuous glucose monitoring is effective
Among adults with insulin-treated diabetes, initiation of continuous glucose monitoring (CGM) by primary care clinicians is associated with clinically meaningful improvements in hemoglobin A1c (HbA1c) and significant reductions in recurrent hospitalizations, according to a study
Diabetes patients in Gaza face survival battle amid war shortages
Insulin and equipment shortages in Gaza pose fatal risks, leading to critical health complications. O recorte ajuda a contextualizar a pauta dentro de Geral.
Don’t eat your greens? A diet taking Yemen by storm has doctors worried
Hospitals in Yemen report increase in workload after struck off doctor encourages diabetes patients not to take insulin.
Drug that delays onset of type 1 diabetes approved in England and Wales
Availability of teplizumab on the NHS – which postpones early stages of disease for up to three years – described as an ‘incredible moment’The world’s first drug to delay the onset of type 1 diabetes is to be made available on the NHS in England and Wales, in the biggest breakthr